W Douglas Weaver

Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial

Lars Wallentin, Robert G. Wilcox, W Douglas Weaver et al. · The Lancet · 2003 · 369 citations

Thrombosis, Oral Ximelagatran, Secondary Prophylaxis +11

Patient-Specific Predictions of Outcomes in Myocardial Infarction for Real-Time Emergency Use: A Thrombolytic Predictive Instrument

H P Selker, John L. Griffith, Joni R. Beshansky et al. · Annals of Internal Medicine · 1997 · 85 citations

Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Experience from the GUSTO-I Trial

Kenneth W. Mahaffey, Christopher B. Granger, Michael A. Sloan et al. · American Heart Journal · 1999 · 48 citations

Thrombosis, Intracranial Hemorrhage, Medicine +9

TNK-tissue plasminogen activator compared with front-loaded tissue plasminogen activator in acute myocardial infarction: primary results of the TIMI 10B trial

CP Cannon, CH McCabe, C. Michael Gibson et al. · Circulation · 1997 · 14 citations

Thrombosis, Timi 10B, Cardiovascular Disease +9